Amplify Seymour Cannabis ETF (CNBS) Technical Analysis & Chart
CNBS Price Chart
Technical Analysis Summary
Based on 9 technical indicators, CNBS shows a Neutral signal with a score of 0/100. The 14-day RSI is at 49.33, indicating neutral conditions.
Technical Signal
Signal Score
RSI (14)
49.33
MACD
N/A
SMA 50 / 200
Bollinger Bands
ATR (14)
$1.17
5.0% of price — Moderate volatilityOBV
-359.9K
On-Balance VolumeSupport & Resistance (20-Day)
Support
$21.87
6.9% below current price
Resistance
$25.34
7.8% above current price
All Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| EMA 12 | 23.45 | Buy |
| RSI 14 | 49.33 | Neutral |
| Bollinger Upper | 25.03 | Neutral |
| Bollinger Middle | 23.50 | Neutral |
| Bollinger Lower | 21.97 | Neutral |
| ATR 14 | 1.17 | Neutral |
| OBV | -359888 | Buy |
| Support | 21.87 | Neutral |
| Resistance | 25.34 | Neutral |
Moving Averages
| Indicator | Value | Price vs MA | Signal |
|---|---|---|---|
| SMA 50 | N/A | N/A | N/A |
| SMA 200 | N/A | N/A | N/A |
| EMA 12 | $23.45 | Above (0.2%) | Buy |
| EMA 26 | N/A | N/A | N/A |
Oscillators & Momentum
RSI Interpretation
The 14-day RSI for CNBS is 49.33. The stock is in neutral territory (between 30 and 70), indicating balanced buying and selling pressure with no extreme momentum reading.
MACD Interpretation
Insufficient data to calculate MACD.
Bollinger Bands Interpretation
CNBS is trading at $23.50 relative to Bollinger Bands of $21.97 (lower), $23.50 (middle), and $25.03 (upper). Price is trading in the middle of the bands, indicating normal volatility and no extreme readings. The band width is $3.06.
Recent Price History
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | $23.05 | $23.50 | $23.05 | $23.50 | 7.5K | +2.29% |
| Mar 12, 2026 | $23.25 | $23.34 | $22.96 | $22.97 | 5.5K | -2.51% |
| Mar 11, 2026 | $22.94 | $23.65 | $22.83 | $23.57 | 7.0K | +2.72% |
| Mar 10, 2026 | $23.76 | $24.03 | $22.85 | $22.94 | 7.1K | -3.90% |
| Mar 9, 2026 | $24.30 | $24.30 | $23.53 | $23.87 | 10.0K | -2.29% |
| Mar 6, 2026 | $22.20 | $24.99 | $22.20 | $24.43 | 19.9K | +7.72% |
| Mar 5, 2026 | $23.83 | $23.94 | $22.51 | $22.68 | 5.4K | -4.26% |
| Mar 4, 2026 | $22.91 | $23.74 | $22.89 | $23.69 | 6.8K | +3.99% |
| Mar 3, 2026 | $21.90 | $22.78 | $21.87 | $22.78 | 10.8K | +1.69% |
| Mar 2, 2026 | $23.37 | $23.37 | $22.40 | $22.40 | 8.2K | -5.67% |
| Feb 27, 2026 | $23.94 | $23.94 | $23.45 | $23.75 | 27.6K | -1.57% |
| Feb 26, 2026 | $24.53 | $24.53 | $23.98 | $24.13 | 7.8K | -1.52% |
| Feb 25, 2026 | $24.51 | $25.05 | $23.89 | $24.50 | 10.4K | +0.12% |
| Feb 24, 2026 | $22.49 | $24.65 | $22.47 | $24.47 | 16.8K | +9.34% |
| Feb 23, 2026 | $22.79 | $23.32 | $22.28 | $22.38 | 21.4K | -0.71% |
| Feb 20, 2026 | $24.90 | $24.90 | $22.45 | $22.54 | 348.5K | -10.52% |
| Feb 19, 2026 | $23.00 | $25.34 | $22.87 | $25.19 | 17.0K | +9.20% |
| Feb 18, 2026 | $23.48 | $23.69 | $23.07 | $23.07 | 5.4K | -1.67% |
| Feb 17, 2026 | $23.51 | $23.66 | $23.27 | $23.46 | 9.1K | -1.16% |
| Feb 13, 2026 | $23.32 | $23.87 | $23.32 | $23.73 | 11.2K | -- |
Frequently Asked Questions
What is CNBS's RSI?
CNBS's 14-day Relative Strength Index (RSI) is currently 49.33. This is in the neutral range (30-70), indicating neither overbought nor oversold conditions.
Is CNBS overbought or oversold?
Based on the RSI reading of 49.33, CNBS is neither overbought nor oversold, trading in the neutral zone between 30 and 70. The stock is trading at $$23.50 relative to Bollinger Bands of $21.97 (lower) to $25.03 (upper).
What is CNBS's MACD signal?
There is currently insufficient data to calculate the MACD for CNBS. At least 26 trading days of data plus 9 days for the signal line are required.
Is CNBS showing a golden cross or death cross?
CNBS is not currently showing either a golden cross or death cross. Insufficient data exists to compare the 50-day and 200-day moving averages.
What are CNBS's support and resistance levels?
Based on the last 20 trading days, CNBS's support level is at $21.87 and resistance is at $25.34. The current price of $23.50 is closer to support, suggesting potential buying interest. The trading range between support and resistance is $3.47 (15.87%).
What is the technical analysis summary for CNBS?
Amplify Seymour Cannabis ETF (CNBS) currently has an overall technical signal of "Neutral" with a score of 0/100. Based on 9 technical indicators, CNBS shows a Neutral signal with a score of 0/100. The 14-day RSI is at 49.33, indicating neutral conditions. Technical analysis should be used in conjunction with fundamental analysis and is not a guarantee of future performance.
CNBS Technical Analysis Overview
Amplify Seymour Cannabis ETF (CNBS) is a publicly traded cannabis company listed on the NYSE. This page provides comprehensive technical analysis including moving averages, oscillators, and key support and resistance levels to help traders and investors analyze CNBS's price action.
Technical indicators are mathematical calculations based on price, volume, or open interest that traders use to evaluate securities and identify trading opportunities. The indicators shown on this page include RSI, MACD, Bollinger Bands, Simple and Exponential Moving Averages, Average True Range (ATR), and On-Balance Volume (OBV).
For a complete overview of Amplify Seymour Cannabis ETF, visit the CNBS stock page. View financial statements on the CNBS financials page. Compare CNBS against other cannabis stocks or explore the cannabis stock rankings.
Disclaimer
The technical analysis and indicators provided on this page are for informational purposes only and should not be considered as financial advice, investment recommendations, or an endorsement of any trading strategy. Technical indicators are based on historical price data and do not guarantee future performance. Cannabis stocks are speculative investments that carry significant risk, including the potential for total loss of capital. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not provide personalized investment advice.